vimarsana.com

Page 4 - ஹைதராபாத் அடிப்படையிலானது பாரத் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

India crosses 300,000 COVID deaths; vaccine drive hit by shortage

India has crossed 300,000 coronavirus deaths, the third country after the United States and Brazil to hit the grim figure, as it battles a huge second wave of infections now affecting the poorer countryside. India’s health ministry on Monday reported 4,454 coronavirus-related deaths over the last 24 hours, with the total death toll now standing at 303,720 after adding 50,000 deaths in just under two weeks. Daily coronavirus infections rose by 222,315, taking the country’s caseload to 26.75 million, according to the health ministry data. The milestone came as slowed vaccine deliveries mar the country’s fight against the pandemic, forcing many to miss their shots, and a rare “black fungus” infection affecting COVID-19 patients worrying the doctors.

Vaccine policy must be guided by transparency

Vaccine policy must be guided by transparency
tribuneindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tribuneindia.com Daily Mail and Mail on Sunday newspapers.

The Covishield Rut: Indians travelling abroad don t really have a Covid vaccine choice

Vaccine Makers Invited To Produce Covaxin To Address Shortage

Vaccine Makers Invited To Produce Covaxin To Address Shortage Vaccine Makers Invited To Produce Covaxin To Address Shortage The statement came on a day when the government announced it hoped to have more than 200 crore doses of coronavirus vaccines between August to December this year. Covaxin is currently produced by Hyderabad-based Bharat Biotech. Highlights Several states have complained of severe vaccine shortage India hopes to have 200 crore doses by the end of the year New Delhi: The central government and Hyderabad-based Bharat Biotech are willing to invite other companies which want to produce Covaxin to help scale up its production, a top government advisor said on Thursday, as India grapples with a dire shortage of coronavirus vaccines.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.